Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial and fungal cell components represent a broad collective of structural and functional molecules that are essential for the survival of pathogenic microorganisms and serve as the primary targets for antimicrobial therapy. This category includes the bacterial peptidoglycan cell wall, which is the target of beta-lactam antibiotics like Penicillin (StatPearls, 2023), and the fungal cell wall composed of chitin and glucans, targeted by echinocandins (Journal of Fungi, 2017). Additionally, it encompasses microbial membranes, where ergosterol serves as a critical target for polyene and azole antifungals (Clinical Microbiology Reviews, 2017), as well as internal machinery such as the 30S and 50S ribosomal subunits targeted by various antibiotic classes (Nature Reviews Microbiology, 2014). These components are also recognized by the host's innate immune system as pathogen-associated molecular patterns (PAMPs) through pattern recognition receptors like Toll-like receptors (NIH, 2021). Because this term aggregates a vast array of distinct molecular entities across different biological kingdoms rather than a single specific protein or receptor, it is classified as a high-level target category rather than a discrete therapeutic target.
Antimicrobial agents target these components through several distinct mechanisms: inhibition of cell wall biosynthesis (e.g., beta-lactams and glycopeptides targeting peptidoglycan; echinocandins targeting fungal beta-glucan), disruption of cell membrane integrity and function (e.g., polyenes binding to ergosterol; polymyxins targeting bacterial LPS), and interference with essential intracellular processes such as protein synthesis (e.g., macrolides and aminoglycosides targeting ribosomes) or nucleic acid replication (e.g., fluoroquinolones targeting DNA gyrase).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial and fungal cell components.